Discovery solutions with Horizon
CRISPR-Cas9 cell lines for every lab
Highly characterized human cell lines that use CRISPR-Cas9 gene-editing to disable genes of interest. Over 4000 gene targets represented in our ready to ship catalogue
The fastest custom generation service, with design to delivery capabilities. Off the shelf KO models available including exclusive optogenetics. Expanding range of high fidelity PDX models
Monitor your assay performance and avoid the possibility of false positives and negatives with characterized controls at precise allelic frequencies
Horizon has established a core expertise in functional genomic screening using siRNA and CRISPR-Cas9 screening platforms. Using these screening techniques, we can help you to find and validate novel drug targets, identify mechanisms of drug resistance or sensitivity and to identify synthetic lethality. For more details click here.